| Diverse types of dermatologic toxicities from immune checkpoint blockade therapy JL Curry, MT Tetzlaff, P Nagarajan, C Drucker, A Diab, SR Hymes, ... Journal of cutaneous pathology 44 (2), 158-176, 2017 | 221 | 2017 |
| Autoimmune dermatologic toxicities from immune checkpoint blockade with anti‐PD‐1 antibody therapy: a report on bullous skin eruptions G Jour, IC Glitza, RM Ellis, CA Torres‐Cabala, MT Tetzlaff, JY Li, ... Journal of cutaneous pathology 43 (8), 688-696, 2016 | 140 | 2016 |
| Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients MT Tetzlaff, KC Nelson, A Diab, GA Staerkel, P Nagarajan, ... Journal for immunotherapy of cancer 6, 1-11, 2018 | 137 | 2018 |
| Keratinocyte carcinomas: current concepts and future research priorities P Nagarajan, MM Asgari, AC Green, SM Guhan, ST Arron, CM Proby, ... Clinical Cancer Research 25 (8), 2379-2391, 2019 | 124 | 2019 |
| Density, distribution, and composition of immune infiltrates correlate with survival in Merkel cell carcinoma L Feldmeyer, CW Hudgens, G Ray-Lyons, P Nagarajan, PP Aung, ... Clinical cancer research 22 (22), 5553-5563, 2016 | 110 | 2016 |
| Lichenoid dermatologic toxicity from immune checkpoint blockade therapy: a detailed examination of the clinicopathologic features MT Tetzlaff, P Nagarajan, S Chon, A Huen, A Diab, P Omar, PP Aung, ... The American Journal of Dermatopathology 39 (2), 121-129, 2017 | 102 | 2017 |
| Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance PP Aung, P Nagarajan, VG Prieto Laboratory Investigation 97 (6), 657-668, 2017 | 85 | 2017 |
| Pilot phase II trial of neoadjuvant immunotherapy in locoregionally advanced, resectable cutaneous squamous cell carcinoma of the head and neck R Ferrarotto, M Amit, P Nagarajan, ML Rubin, Y Yuan, D Bell, ... Clinical Cancer Research 27 (16), 4557-4565, 2021 | 76 | 2021 |
| Ayurvedic herbal medicine and lead poisoning KS Gunturu, P Nagarajan, P McPhedran, TR Goodman, ME Hodsdon, ... Journal of hematology & oncology 4, 1-6, 2011 | 75 | 2011 |
| Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors AS Yilmaz, HG Ozer, JL Gillespie, DC Allain, MN Bernhardt, KC Furlan, ... Cancer 123 (7), 1184-1193, 2017 | 73 | 2017 |
| Dual expression of TCF4 and CD123 is highly sensitive and specific for blastic plasmacytoid dendritic cell neoplasm N Sukswai, PP Aung, CC Yin, S Li, W Wang, SA Wang, V Ortega, ... The American journal of surgical pathology 43 (10), 1429-1437, 2019 | 69 | 2019 |
| Primary cutaneous T-cell lymphomas showing gamma-delta (γδ) phenotype and predominantly epidermotropic pattern are clinicopathologically distinct from classic primary cutaneous … ED Merrill, R Agbay, RN Miranda, PP Aung, MT Tetzlaff, KH Young, ... The American Journal of Surgical Pathology 41 (2), 204-215, 2017 | 68 | 2017 |
| Tumor thickness and mitotic rate robustly predict melanoma-specific survival in patients with primary vulvar melanoma: a retrospective review of 100 cases P Nagarajan, JL Curry, J Ning, J Piao, CA Torres-Cabala, PP Aung, ... Clinical Cancer Research 23 (8), 2093-2104, 2017 | 58 | 2017 |
| Association of immunosuppression with outcomes of patients with cutaneous squamous cell carcinoma of the head and neck S Tam, CMKL Yao, M Amit, M Gajera, X Luo, R Treistman, A Khanna, ... JAMA Otolaryngology–Head & Neck Surgery 146 (2), 128-135, 2020 | 57 | 2020 |
| Erythema nodosum‐like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy—Report of 2 patients MT Tetzlaff, AA Jazaeri, CA Torres‐Cabala, BR Korivi, GA Landon, ... Journal of cutaneous pathology 44 (12), 1080-1086, 2017 | 54 | 2017 |
| Evaluating peptide mass fingerprinting-based protein identification S Damodaran, TD Wood, P Nagarajan, RA Rabin Genomics, Proteomics and Bioinformatics 5 (3-4), 152-157, 2007 | 54 | 2007 |
| Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel finding RN Al‐Rohil, CA Torres‐Cabala, A Patel, MT Tetzlaff, D Ivan, P Nagarajan, ... Journal of cutaneous pathology 43 (12), 1161-1166, 2016 | 48 | 2016 |
| Ocular preservation with neoadjuvant vismodegib in patients with locally advanced periocular basal cell carcinoma O Sagiv, P Nagarajan, R Ferrarotto, TJ Kandl, SD Thakar, BS Glisson, ... British Journal of Ophthalmology 103 (6), 775-780, 2019 | 43 | 2019 |
| Ets1 blocks terminal differentiation of keratinocytes and induces expression of matrix metalloproteases and innate immune mediators P Nagarajan, SS Chin, D Wang, S Liu, S Sinha, LA Garrett-Sinha Journal of cell science 123 (20), 3566-3575, 2010 | 42 | 2010 |
| Ets1 induces dysplastic changes when expressed in terminally-differentiating squamous epidermal cells P Nagarajan, N Parikh, LA Garrett-Sinha, S Sinha PloS one 4 (1), e4179, 2009 | 40 | 2009 |
Rami Al-RohilDuke UniversityVerified email at duke.edu
